Persistent and recurrent hypercalcemia are uncommon in dogs undergoing surgical treatment for primary hyperparathyroidism.

IF 1.4 3区 农林科学 Q2 VETERINARY SCIENCES
Natalia L Rosa-Padilla, Brenley Fuller, Cambrie Schumacher, Cassie Lux, Kelley Thieman, Kathryn Biehl, Kathleen Ham
{"title":"Persistent and recurrent hypercalcemia are uncommon in dogs undergoing surgical treatment for primary hyperparathyroidism.","authors":"Natalia L Rosa-Padilla, Brenley Fuller, Cambrie Schumacher, Cassie Lux, Kelley Thieman, Kathryn Biehl, Kathleen Ham","doi":"10.2460/ajvr.26.03.0104","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To report the proportion of cases, causes, and definitions of recurrent and persistent hypercalcemia in dogs following surgical removal of autonomously functioning parathyroid tissue.</p><p><strong>Methods: </strong>Retrospective review of medical records from 3 academic veterinary hospitals (2012 to 2022) identified dogs with surgically treated primary hyperparathyroidism. Data included signalment, clinical signs, diagnostics, treatment, histopathology, and outcomes. Dogs were categorized by follow-up: ≤ 6 months (group 1) or > 6 months (group 2). Descriptive statistics were performed. The Mann-Whitney U test compared preoperative ionized calcium and parathyroid hormone between dogs with persistent versus resolved hypercalcemia.</p><p><strong>Results: </strong>202 dogs met the inclusion criteria. Group 1 included 123 dogs, and group 2 included 79 dogs. Mean age was 10.7 ± 2.23 years, with no sex predilection. Hypercalcemia-associated clinical signs occurred in 68% (138 of 202) of dogs. Histopathology revealed parathyroid adenoma (58% [135 of 233]), hyperplasia (24% [56 of 233]), and carcinoma (7% [10 of 233]) as most common. Persistent hypercalcemia occurred in 25 of 202 dogs (12.4%), primarily due to incorrect surgical removal or multiglandular disease. Preoperative ionized calcium and parathyroid hormone did not differ between persistent and resolved cases. Recurrent hypercalcemia occurred in 1 of 79 (1.3%) dogs in group 2, associated with a new mass. Fifteen dogs underwent a second surgery; 1 dog required a third surgery.</p><p><strong>Conclusions: </strong>Persistent and recurrent hypercalcemia were uncommon (12.4% and 1.3%, respectively). Multiglandular disease and incorrect surgical excision were the leading causes of persistent hypercalcemia.</p><p><strong>Clinical relevance: </strong>This study emphasizes that persistent and recurrent hypercalcemia are uncommon but require diligent perioperative planning and monitoring.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":"1-9"},"PeriodicalIF":1.4000,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of veterinary research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.2460/ajvr.26.03.0104","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To report the proportion of cases, causes, and definitions of recurrent and persistent hypercalcemia in dogs following surgical removal of autonomously functioning parathyroid tissue.

Methods: Retrospective review of medical records from 3 academic veterinary hospitals (2012 to 2022) identified dogs with surgically treated primary hyperparathyroidism. Data included signalment, clinical signs, diagnostics, treatment, histopathology, and outcomes. Dogs were categorized by follow-up: ≤ 6 months (group 1) or > 6 months (group 2). Descriptive statistics were performed. The Mann-Whitney U test compared preoperative ionized calcium and parathyroid hormone between dogs with persistent versus resolved hypercalcemia.

Results: 202 dogs met the inclusion criteria. Group 1 included 123 dogs, and group 2 included 79 dogs. Mean age was 10.7 ± 2.23 years, with no sex predilection. Hypercalcemia-associated clinical signs occurred in 68% (138 of 202) of dogs. Histopathology revealed parathyroid adenoma (58% [135 of 233]), hyperplasia (24% [56 of 233]), and carcinoma (7% [10 of 233]) as most common. Persistent hypercalcemia occurred in 25 of 202 dogs (12.4%), primarily due to incorrect surgical removal or multiglandular disease. Preoperative ionized calcium and parathyroid hormone did not differ between persistent and resolved cases. Recurrent hypercalcemia occurred in 1 of 79 (1.3%) dogs in group 2, associated with a new mass. Fifteen dogs underwent a second surgery; 1 dog required a third surgery.

Conclusions: Persistent and recurrent hypercalcemia were uncommon (12.4% and 1.3%, respectively). Multiglandular disease and incorrect surgical excision were the leading causes of persistent hypercalcemia.

Clinical relevance: This study emphasizes that persistent and recurrent hypercalcemia are uncommon but require diligent perioperative planning and monitoring.

在接受原发性甲状旁腺功能亢进手术治疗的狗中,持续和复发的高钙血症是罕见的。
目的:报告手术切除自主功能甲状旁腺组织后复发性和持续性高钙血症的病例比例、原因和定义。方法:回顾性分析3家兽医院2012 - 2022年收治的经手术治疗的原发性甲状旁腺功能亢进犬的病历。数据包括信号、临床体征、诊断、治疗、组织病理学和结果。按随访时间分为≤6个月(1组)和bb0 ~ 6个月(2组)。进行描述性统计。Mann-Whitney U试验比较了持续性高钙血症和化解性高钙血症狗术前的离子钙和甲状旁腺激素。结果:202只狗符合纳入标准。1组123只,2组79只。平均年龄10.7±2.23岁,无性别偏好。68%(202 / 138)的狗出现高钙血症相关临床症状。组织病理学显示最常见的是甲状旁腺瘤(58%[233 / 135])、增生(24%[233 / 56])和癌(7%[233 / 10])。202只狗中有25只(12.4%)出现持续性高钙血症,主要是由于不正确的手术切除或多腺疾病。术前离子钙和甲状旁腺激素在持续和解决病例之间没有差异。2组79只狗中有1只(1.3%)出现复发性高钙血症,并伴有新的肿块。15只狗接受了第二次手术;有一只狗需要第三次手术。结论:持续性高钙血症和复发性高钙血症不常见(分别为12.4%和1.3%)。多腺体疾病和不正确的手术切除是持续高钙血症的主要原因。临床意义:本研究强调持续性和复发性高钙血症并不常见,但需要周密的围手术期计划和监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
10.00%
发文量
186
审稿时长
3 months
期刊介绍: The American Journal of Veterinary Research supports the collaborative exchange of information between researchers and clinicians by publishing novel research findings that bridge the gulf between basic research and clinical practice or that help to translate laboratory research and preclinical studies to the development of clinical trials and clinical practice. The journal welcomes submission of high-quality original studies and review articles in a wide range of scientific fields, including anatomy, anesthesiology, animal welfare, behavior, epidemiology, genetics, heredity, infectious disease, molecular biology, oncology, pharmacology, pathogenic mechanisms, physiology, surgery, theriogenology, toxicology, and vaccinology. Species of interest include production animals, companion animals, equids, exotic animals, birds, reptiles, and wild and marine animals. Reports of laboratory animal studies and studies involving the use of animals as experimental models of human diseases are considered only when the study results are of demonstrable benefit to the species used in the research or to another species of veterinary interest. Other fields of interest or animals species are not necessarily excluded from consideration, but such reports must focus on novel research findings. Submitted papers must make an original and substantial contribution to the veterinary medicine knowledge base; preliminary studies are not appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书